BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 05:05 pm

Intimation of Closure of Trading Window

Entero Healthcare Solutions Ltd · 544122

✦ AI Summary

Entero Healthcare Solutions Ltd has announced the closure of its trading window for designated persons and their immediate relatives. The window will be closed from July 01, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. This is a standard compliance measure in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading. The date for the Board Meeting to approve these results will be intimated subsequently.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Entero Healthcare Solutions Ltd - 544122 - Closure of Trading Window

Attachments (1)

📄

7f725a2e-f389-4d63-9989-f27565a1be8c.pdf

pdf

Download →
View document text
Ref: 15/SE/LC/2026-27 Date: June 23, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Intimation of Closure of Trading Window This is to inform you that pursuant to the Company’s Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for dealing in securities of the Company by the Designated Persons of the Company and their immediate relatives will be closed with effect from July 01, 2026 and shall remain closed up to 48 (Forty Eight) hours after declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. The date of the Board Meeting to consider the aforesaid Unaudited Financial Results of the Company will be intimated in due course of time. This is for your information and records. Yours Faithfully For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- General Counsel, Company Secretary & Compliance Officer